ANGLE plc, a medical diagnostic company, provides cancer diagnostics and foetal health products. Its lead product is Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. The resulting liquid biopsy (simple blood test) enables the investigation of mutations in the patient?s cancer for personalized cancer care. The company primarily focuses on the cancer market. ANGLE plc was founded in 2004 and is based in Guildford, the United Kingdom.

Appointments: Interim CEO and senior board advisor

Strategy Update

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ANGLE Plc (AGL LN)

Appointments: Interim CEO and senior board advisor

Strategy Update

Presentation of Data on Glioblastoma

Board Changes

Interim Results

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)